211 related articles for article (PubMed ID: 11556591)
21. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.
Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR
Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of and factors for non-compliance to antituberculous treatment].
Cáceres Fde M; Orozco LC
Biomedica; 2007 Dec; 27(4):498-504. PubMed ID: 18320117
[TBL] [Abstract][Full Text] [Related]
24. [Factors related to early case detection of tuberculosis in health service facilities for the elderly].
Ohmori M; Wada M; Yoshiyama T; Uchimura K
Kekkaku; 2003 Jun; 78(6):435-42. PubMed ID: 12872702
[TBL] [Abstract][Full Text] [Related]
25. Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of H pital Albert Schweitzer.
Ollé-Goig JE; Alvarez J
Int J Tuberc Lung Dis; 2001 Feb; 5(2):137-41. PubMed ID: 11258507
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda.
Elbireer S; Guwatudde D; Mudiope P; Nabbuye-Sekandi J; Manabe YC
Trop Med Int Health; 2011 Aug; 16(8):981-7. PubMed ID: 21585625
[TBL] [Abstract][Full Text] [Related]
27. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel.
Chemtob D; Epstein L; Slater PE; Weiler-Ravell D
Isr Med Assoc J; 2001 Jul; 3(7):479-83. PubMed ID: 11791411
[TBL] [Abstract][Full Text] [Related]
29. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
[TBL] [Abstract][Full Text] [Related]
30. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.
Zvavamwe Z; Ehlers VJ
Int J Nurs Stud; 2009 Mar; 46(3):302-9. PubMed ID: 18995854
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal.
Bam TS; Gunneberg C; Chamroonsawasdi K; Bam DS; Aalberg O; Kasland O; Shiyalap K; Srisorrachatr S
Int J Tuberc Lung Dis; 2006 Mar; 10(3):270-6. PubMed ID: 16562706
[TBL] [Abstract][Full Text] [Related]
32. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
[TBL] [Abstract][Full Text] [Related]
33. Care of HIV complications in patients receiving anti-tuberculosis treatment in hospitals in Malawi.
Chimzizi RB; Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Oct; 5(10):979-81. PubMed ID: 11605895
[TBL] [Abstract][Full Text] [Related]
34. Current status of treatment completion and fatality among tuberculosis patients in Spain.
Caylà JA; Caminero JA; Rey R; Lara N; Vallés X; Galdós-Tangüis H;
Int J Tuberc Lung Dis; 2004 Apr; 8(4):458-64. PubMed ID: 15141739
[TBL] [Abstract][Full Text] [Related]
35. A preliminary study of the influence of HIV infection in the transmission of tuberculosis.
Mohammad Z; Naing NN; Salleh R; Ahmad N; Hamzah WM; Mahmud R
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):92-8. PubMed ID: 12118468
[TBL] [Abstract][Full Text] [Related]
36. A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting.
MacIntyre CR; Goebel K; Brown GV; Skull S; Starr M; Fullinfaw RO
Int J Tuberc Lung Dis; 2003 Sep; 7(9):848-54. PubMed ID: 12971668
[TBL] [Abstract][Full Text] [Related]
37. Approaches to improving adherence to antituberculosis therapy--South Carolina and New York, 1986-1991.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Feb; 42(4):74-5, 81. PubMed ID: 8429808
[TBL] [Abstract][Full Text] [Related]
38. Medical and social consequences of tuberculosis in rural Ethiopia.
Getahun H
Ethiop Med J; 1999 Jul; 37(3):147-53. PubMed ID: 11957311
[TBL] [Abstract][Full Text] [Related]
39. TB compliance and directly observed therapy.
Ogunyemi SO
Niger J Med; 2001; 10(1):42. PubMed ID: 11705055
[No Abstract] [Full Text] [Related]
40. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey.
Balbay O; Annakkaya AN; Arbak P; Bilgin C; Erbas M
Jpn J Infect Dis; 2005 Jun; 58(3):152-8. PubMed ID: 15973006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
